Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL

1994 Consensus Conference on Acute GVHD Grading.

1995 • 4,743 citations

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]

1995 • 2,026 citations

Bone-Marrow Transplantation

1975 • 1,667 citations

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

1990 • 1,544 citations

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1979 • 1,538 citations

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

1986 • 1,453 citations

Bone-Marrow Transplantation

1975 • 1,196 citations

Antileukemic Effect of Chronic Graft-versus-Host Disease

1981 • 1,112 citations

Marrow Transplantation from Related Donors Other Than HLA-Identical Siblings

1985 • 844 citations

Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

1991 • 793 citations

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

1995 • 772 citations

The biology of graft-versus-host reactions.

1966 • 627 citations

Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor [see comments]

1995 • 616 citations

Mismatches of Minor Histocompatibility Antigens between HLA-Identical Donors and Recipients and the Development of Graft-Versus-Host Disease after Bone Marrow Transplantation

1996 • 603 citations

A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment

1991 • 577 citations

Graft-versus-myeloma effect: proof of principle

1996 • 565 citations

Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease

1995 • 535 citations

Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) [see comments]

1995 • 508 citations

Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation

1996 • 439 citations

Identification of a Graft Versus Host Disease-Associated Human Minor Histocompatibility Antigen

1995 • 429 citations

Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate [see comments]

1992 • 367 citations

Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic Neoplasms

1989 • 361 citations

Human H-Y: a Male-Specific Histocompatibility Antigen Derived from the SMCY Protein

1995 • 358 citations

Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease

1986 • 338 citations

The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation

1995 • 292 citations

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

1995 • 273 citations

Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease

1993 • 266 citations

In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice

1994 • 245 citations

Unrelated donor marrow transplantation in children

1995 • 236 citations

Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells.

1995 • 216 citations

Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)

1995 • 198 citations

Thalidomide as salvage therapy for chronic graft-versus-host disease

1995 • 194 citations

Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program

1993 • 193 citations

Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation

1995 • 183 citations

Graft-versus-host disease and the Th1/Th2 paradigm

1996 • 158 citations

Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome

1995 • 140 citations

The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection

1996 • 138 citations

Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia

1994 • 133 citations

What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?

1990 • 129 citations

MARROW GRAFTS BY COMBINED MARROW AND LEUKOCYTE INFUSIONS IN UNRELATED DOGS SELECTED BY HISTOCOMPATIBILITY TYPING

1968 • 128 citations

CTLA4Ig TREATMENT AMELIORATES THE LETHALITY OF MURINE GRAFT-VERSUS-HOST DISEASE ACROSS MAJOR HISTOCOMPATIBILITY COMPLEX BARRIERS

1994 • 123 citations

Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient

1995 • 116 citations

Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation

1977 • 116 citations

FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation

1996 • 103 citations

Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study

1995 • 95 citations

Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantation

1996 • 90 citations

Marrow Engraftment by Allogeneic Leukocytes in Lethally Irradiated Dogs

1967 • 85 citations

Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.

1995 • 69 citations

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens

1996 • 59 citations

Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers.

1995 • 56 citations

Allogenic transplant of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors

1996 • 55 citations

Involvement of α1 and α4 integrins in gut mucosal injury of graft-versus-host disease

1995 • 47 citations

Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia

1996 • 47 citations

Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.

1995 • 47 citations

Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.

1995 • 45 citations

TCR gamma/delta positive lymphocytes after allogeneic bone marrow transplantation.

1992 • 38 citations

Different T-cell receptor repertoires between lesions and peripheral blood in acute graft-versus-host disease after allogeneic bone marrow transplantation

1996 • 31 citations

IMMUNOHISTOCHEMICAL ANALYSIS OF T CELL PHENOTYPES IN PATIENTS WITH GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION

1995 • 29 citations

Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1

1995 • 24 citations

An immunohistological study of gamma/delta lymphocytes in human cutaneous graft-versus-host disease.

1991 • 21 citations

Immunohistological study of distribution of gamma/delta lymphocytes after allogeneic bone marrow transplantation.

1992 • 13 citations

Deleted Work

1955 • 0 citations